Indication
Crohn's Disease
The Crohn's Disease pipeline: 67 tracked drugs, 37 approved for this indication.
37 approved / phase 46 Phase 31 Phase 2/310 Phase 23 Phase 1/29 Phase 11 preclinical / unstaged
Compare the share prices of listed companies in Crohn's Disease →
Total attributable cost
$46.6B
$46,100/patient
Drug spend
Not yet sourced
All severities · US